Spreker: Dr. Marc Tischkowitz, Cambridge
Onderwerp: ERN-GENTURIS webinar on Hereditary Breast and Ovarian Cancer – BRCA1, BRCA2 and the basic
Dr. Marc Tischkowitz from the University of Cambridge will share his expertise during the second ERN-GENTURIS webinar, which will take place on 20 May, 16:00 CEST. BRCA1 and BRCA2 are two of the most important genes in inherited cancer predisposition. They are probably the most sequenced and characterised genes in clinical medicine, but many unanswered questions remain.
This webinar will provide an overview of these genes from their discovery in the mid 90’s to the current day. It will focus on the known cancer predisposition spectrum, cancer risk estimates, the development of mainstream testing and current controversies in the management of individuals who carry pathogenic variants in these genes. If you would like to join this webinar, please register here.
RT @GeneticAMS: Dr. Erik Sistermans, head of AGDx Genome Diagnostics, has been appointed as professor in Human Genetics, in particular pren…